AARD · Aardvark Therapeutics, Inc. · Executive Compensation
Market Cap
$103.08M
Shares
21.88M
Volume · Oct 8
315.97K
Avg daily vol (3M)
211.15K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David (Zhongwei) Zhang | Class II director | Appointed | 2026-10-08 |
| Derrick C. Li | Chief Business Officer | Appointed | 2026-02-12 |
| Nelson Sun | Chief Operating Officer | Appointed | 2026-02-12 |
| Bryan Jones, Ph.D. | Chief Operating Officer | Resigned | 2026-02-12 |